Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published o ...

Guideline-directed medical therapy for heart failure (HF) with reduced ejection fraction can entail high out-of-pocket (OOP) costs, prompting concerns about financial toxicity and access. OOP costs ...

Note: for the purposes of this tool, people living with heart failure with a mildly reduced ejection fraction (HFmrEF) should be considered as living with heart failure with reduced ejection fraction ...

Only 24.9 percent of Colorado residents had obesity, and its heart disease and stroke mortality rates were comparatively low too, at 131.4 and 33.8 people per 100,000, respectively. Also in the ...

with multiple-cause and more severe heart failure (reduced ejection fraction) having the worst outcome. Cardiovascular risk factors such as smoking and diabetes, valvular disease, diuretic use ...

For example, with statins, increased non-cardiovascular mortality in older age may negate the survival benefit of reduced cardiovascular mortality seen in younger people.36 People with heart failure ...

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR), according to a study ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well ... One study showed that treatment with candesartan reduced hospital admissions in this ...

Colorado QB Shedeur Sanders avoided an ejection for shoving the referee in the second half of No. 16 Colorado's 37-21 loss to Kansas. Officials appeared to miss Sanders shoving the referee in the ...

We present a laminar fluid ejection (LFE) method for precise delivery of medications ... Then, we conducted three proof-of-concept in-vivo imaging studies to confirm olfactory delivery in humans.

In 2022, empagliflozin (Jardiance) was approved for a broader indication in heart failure across the spectrum of ejection fraction (EF). In 2023, another SGLT2 inhibitor, dapagliflozin (Farxiga ...